The Power of Hope
Molecule shows potential to combat tumor treatment resistance
June 20, 2024
Researchers at Mays Cancer Center and from the Department of Obstetrics and Gynecology at The University of Texas Health Science Center at San Antonio have made significant progress in studying a promising new molecule that inhibits the ability of glioblastoma multiforme (GBM) tumors to repair themselves.
Mays Cancer Center conducts groundbreaking glioblastoma research
June 20, 2024
Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma multiforme (GBM). The Mays Cancer Center, one of four National Cancer Institute-designated Cancer Centers in Texas, is the only cancer center in America to conduct this trial.
University of Texas team studies compounds aimed at brain cancer treatment
June 20, 2024
$3M National Cancer Institute grant to make compounds to treat glioblastoma multiforme (GBM) tumors, an aggressive brain cancer associated with the worst overall survival rates among all human cancers Scientists from Mays Cancer Center and from the Department of Obstetrics and Gynecology at The University of Texas Health Science Center at San Antonio, along with […]